Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-4/A Registration of securities (foreign)
- 10.13 License Agreement, Dated As of April 18, 2022, by and Between Filament Health Corp. and Psyence Biomed Corp
- 10.14 Licence Agreement, Dated As of June 27, 2023, by and Between Filament Health Corp. and Neolumina Bioscience Inc
- 10.15 License and Supply Agreement, Dated As of August 22, 2023, by and Between Filament Health Corp. and Reset Pharmaceuticals, Inc
- 23.1 Consent of Marcum LLP
- 23.2 Consent of Crowe Mackay LLP
Associated filings
- 8 Dec 23 424B3 Prospectus supplement
- 7 Dec 23 424B3 Prospectus supplement
- 14 Nov 23 EFFECT Notice of effectiveness
- 13 Nov 23 424B3 Prospectus supplement
- 13 Nov 23 F-4/A Registration of securities (foreign) (amended)
- 7 Nov 23 F-4/A Registration of securities (foreign) (amended)
-
13 Oct 23 F-4/A Registration of securities (foreign) (amended)
- 22 Sep 23 F-4/A Registration of securities (foreign) (amended)
- 14 Aug 23 F-4 Registration of securities (foreign)
1427702 B.C. similar filings
Filing view
External links
Exhibit 23.2
INDEPENDENT REGISTERED (WITHDRAWL PENDING) PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of 1427702 B.C. Ltd. on Amendment No. 2 to Form F-4 of our report dated June 19, 2023 with respect to our audits of the consolidated financial statements of Filament Health Corp. as of December 31, 2022 and 2021, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in this Registration Statement.
/s/ Crowe Mackay LLP
Crowe Mackay LLP
Vancouver, BC
October 13, 2023